Trillium Asset Management LLC Sells 40 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trillium Asset Management LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 667 shares of the medical equipment provider’s stock after selling 40 shares during the period. Trillium Asset Management LLC’s holdings in Intuitive Surgical were worth $348,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new stake in Intuitive Surgical during the fourth quarter valued at $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $36,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last quarter. 0.90% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Stifel Nicolaus boosted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Robert W. Baird reduced their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research report on Tuesday. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Erste Group Bank cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Trading Up 1.7 %

NASDAQ:ISRG opened at $492.06 on Thursday. The business’s 50-day moving average is $564.39 and its 200 day moving average is $531.62. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $175.26 billion, a P/E ratio of 76.76, a P/E/G ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.